These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 18668687)
1. The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor. Frankenberg T; Miloh T; Chen FY; Ananthanarayanan M; Sun AQ; Balasubramaniyan N; Arias I; Setchell KD; Suchy FJ; Shneider BL Hepatology; 2008 Dec; 48(6):1896-905. PubMed ID: 18668687 [TBL] [Abstract][Full Text] [Related]
2. Bile salt excretory pump: biology and pathobiology. Suchy FJ; Ananthanarayanan M J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395 [TBL] [Abstract][Full Text] [Related]
3. Phospholipase D2 mediates signaling by ATPase class I type 8B membrane 1. Chen F; Ghosh A; Shneider BL J Lipid Res; 2013 Feb; 54(2):379-85. PubMed ID: 23213138 [TBL] [Abstract][Full Text] [Related]
4. ATPase Class I Type 8B Member 1 and protein kinase C zeta induce the expression of the canalicular bile salt export pump in human hepatocytes. Chen F; Ellis E; Strom SC; Shneider BL Pediatr Res; 2010 Feb; 67(2):183-7. PubMed ID: 19809379 [TBL] [Abstract][Full Text] [Related]
5. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Chen F; Ananthanarayanan M; Emre S; Neimark E; Bull LN; Knisely AS; Strautnieks SS; Thompson RJ; Magid MS; Gordon R; Balasubramanian N; Suchy FJ; Shneider BL Gastroenterology; 2004 Mar; 126(3):756-64. PubMed ID: 14988830 [TBL] [Abstract][Full Text] [Related]
6. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. Ananthanarayanan M; Balasubramanian N; Makishima M; Mangelsdorf DJ; Suchy FJ J Biol Chem; 2001 Aug; 276(31):28857-65. PubMed ID: 11387316 [TBL] [Abstract][Full Text] [Related]
7. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1. Alvarez L; Jara P; Sánchez-Sabaté E; Hierro L; Larrauri J; Díaz MC; Camarena C; De la Vega A; Frauca E; López-Collazo E; Lapunzina P Hum Mol Genet; 2004 Oct; 13(20):2451-60. PubMed ID: 15317749 [TBL] [Abstract][Full Text] [Related]
8. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. Yu J; Lo JL; Huang L; Zhao A; Metzger E; Adams A; Meinke PT; Wright SD; Cui J J Biol Chem; 2002 Aug; 277(35):31441-7. PubMed ID: 12052824 [TBL] [Abstract][Full Text] [Related]
9. ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained. Cai SY; Gautam S; Nguyen T; Soroka CJ; Rahner C; Boyer JL Gastroenterology; 2009 Mar; 136(3):1060-9. PubMed ID: 19027009 [TBL] [Abstract][Full Text] [Related]
10. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma. Chen Y; Song X; Valanejad L; Vasilenko A; More V; Qiu X; Chen W; Lai Y; Slitt A; Stoner M; Yan B; Deng R Hepatology; 2013 Apr; 57(4):1530-41. PubMed ID: 23213087 [TBL] [Abstract][Full Text] [Related]
11. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor. Deng R; Yang D; Yang J; Yan B J Pharmacol Exp Ther; 2006 Apr; 317(1):317-25. PubMed ID: 16371446 [TBL] [Abstract][Full Text] [Related]
12. Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis. Ananthanarayanan M; Li Y; Surapureddi S; Balasubramaniyan N; Ahn J; Goldstein JA; Suchy FJ Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G771-81. PubMed ID: 21330447 [TBL] [Abstract][Full Text] [Related]
13. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes. Balasubramaniyan N; Luo Y; Sun AQ; Suchy FJ J Biol Chem; 2013 May; 288(19):13850-62. PubMed ID: 23546875 [TBL] [Abstract][Full Text] [Related]
14. The hypolipidemic agent guggulsterone regulates the expression of human bile salt export pump: dominance of transactivation over farsenoid X receptor-mediated antagonism. Deng R; Yang D; Radke A; Yang J; Yan B J Pharmacol Exp Ther; 2007 Mar; 320(3):1153-62. PubMed ID: 17135343 [TBL] [Abstract][Full Text] [Related]
15. Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump. Cui J; Huang L; Zhao A; Lew JL; Yu J; Sahoo S; Meinke PT; Royo I; Pelaez F; Wright SD J Biol Chem; 2003 Mar; 278(12):10214-20. PubMed ID: 12525500 [TBL] [Abstract][Full Text] [Related]
16. Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1. Ananthanarayanan M; Li S; Balasubramaniyan N; Suchy FJ; Walsh MJ J Biol Chem; 2004 Dec; 279(52):54348-57. PubMed ID: 15471871 [TBL] [Abstract][Full Text] [Related]
17. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters. Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018 [TBL] [Abstract][Full Text] [Related]
18. Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin-Darby canine kidney cells. Harris MJ; Kagawa T; Dawson PA; Arias IM J Gastroenterol Hepatol; 2004 Jul; 19(7):819-25. PubMed ID: 15209631 [TBL] [Abstract][Full Text] [Related]
19. Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Plass JR; Mol O; Heegsma J; Geuken M; Faber KN; Jansen PL; Müller M Hepatology; 2002 Mar; 35(3):589-96. PubMed ID: 11870371 [TBL] [Abstract][Full Text] [Related]
20. 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor. Honjo Y; Sasaki S; Kobayashi Y; Misawa H; Nakamura H J Endocrinol; 2006 Mar; 188(3):635-43. PubMed ID: 16522742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]